RVMD

Revolution Medicines Inc

A maker of experimental medicines designed to target RAS proteins, the 'switches' that drive pancreatic, lung, and colorectal cancers — proteins long dubbed 'undruggable.' It was founded in 2014 by three chemical biologists, including the University of California scientist Kevan Shokat, whose lab cracked how to reach RAS, and was originally named Midasyn. Its employees call themselves 'Revolutionaries.'

CONVERTIBLEUnderlying: RVMD 0.5 05/01/33CUSIP: 76155XAA8HealthcareUS1 derivative reporter

0.50% Convertible Senior Notes due 2033

Ownership Activity Financials Filings

RVMD

RVMD

Other Events

Results of Operations and Financial Condition

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements

Results of Operations and Financial Condition

Entry into a Material Definitive Agreement

Other Events

Other Events

Results of Operations and Financial Condition